JPRN-UMIN000052846已完成Unknown
sefulness of belimumab in adult patients with systemic lupus erythematosus evaluated using single indexes: a meta-analysis and systematic review. - Usefulness of belimumab in adult patients with systemic lupus erythematosus evaluated using single indexes: a meta-analysis and systematic review.
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 8,197
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Other
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •We exclude clinical studies that meet the following exclusion criteria: 1) not interventional studies; 2) non-original research articles such as reviews, case reports, letters, and research protocols; 3) no data description; 4) studies in children; 5) patients with lupus nephritis; 6) single-dose studies.
研究者
相似试验
进行中（未招募）
1 期
A study to investigate belimumab in IMGIdiopathic Membranous Glomerulonephropathy (IMGN)MedDRA version: 16.1 Level: LLT Classification code 10027170 Term: Membranous nephropathy System Organ Class: 100000004857EUCTR2012-000385-38-GBGlaxoSmithKline Research and Development Ltd14
进行中（未招募）
1 期
Safety and efficacy of Belimumab After B cell depletion therapy in systemic LUPUS erythematosus – BEAT LUPUSMedDRA version: 20.0Level: PTClassification code 10042945Term: Systemic lupus erythematosusSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersSystemic Lupus ErythematosusEUCTR2015-005543-14-GBniversity College London50
进行中（未招募）
1 期
A phase II trial of belimumab in combination withrituximab/venetoclax in patients with refractory orrelapsed chronic lymphocytic leukemiaRefractory or relapsed chronic lymphocytic leukemiaMedDRA version: 21.0Level: LLTClassification code 10009310Term: CLLSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-002622-87-DEniversity Hospital Tuebingen120
招募中
1 期
A phase II trial of belimumab in combination with rituximab/venetoclax in patients with refractory or relapsed chronic lymphocytic leukemiarefractory or relapsed chronic lymphocytic leukemiaMedDRA version: 21.0Level: LLTClassification code: 10008976Term: Chronic lymphocytic leukemia Class: 10029104CTIS2024-511474-68-00niversitaetsklinikum Tuebingen AöR120
尚未招募
2 期
Efficacy and safety of adalimumab in patients with peripheral spondyloarthritis without ankylosing spondylitis or psoriatic arthritis.NL-OMON32839Academisch Medisch Centrum40